E.E. Geduld’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

E.E. Geduld’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-143	Closed	-$42K	–	280
2015 Q2	$42K	Sell	143 -143	-50%	-$43.2K	0.03%	245
2015 Q1	$79K	Buy	+286	New	+$124K	0.05%	206
2014 Q2	–	Sell	-143	Closed	-$64K	–	346
2014 Q1	$64K	Sell	143 -214	-60%	-$97.1K	0.03%	245
2013 Q4	$160K	Buy	+357	New	+$156K	0.08%	212

Other funds holding DMK

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

E.E. Geduld's DMK Position: Q3 2015 in Review

E.E. Geduld sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q3 2015, closing a stake of 143 shares — an estimated $42K sold.

E.E. Geduld first reported a position in DMK in Q4 2013 and held it in 4 quarters. The position peaked at $160K in Q4 2013. 28 funds tracked by Wall St. Rank hold DMK as of Q3 2015.

E.E. Geduld reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q3 2015 after selling out during the quarter.
E.E. Geduld sold 143 DMK Pharmaceuticals Corporation Common Stock shares in Q3 2015, an estimated $42K.
E.E. Geduld first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2013 and held it in 4 quarters.
E.E. Geduld's DMK Pharmaceuticals Corporation Common Stock position peaked at $160K in Q4 2013.
28 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q3 2015.

Based on E.E. Geduld's 13F filing for Q3 2015, filed 6 Nov 2015.